Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent
dc.contributor.author | El-Gendy, Nashwa | |
dc.contributor.author | Aillon, Kristin L. | |
dc.contributor.author | Berkland, Cory J. | |
dc.date.accessioned | 2017-03-14T20:14:19Z | |
dc.date.available | 2017-03-14T20:14:19Z | |
dc.date.issued | 2011-05-31 | |
dc.identifier.citation | El-Gendy, Nashwa, Kristin L. Aillon, and Cory Berkland. "Dry Powdered Aerosols of Diatrizoic Acid Nanoparticle Agglomerates as a Lung Contrast Agent." International Journal of Pharmaceutics 391.1-2 (2010): 305-12. | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/23408 | |
dc.description.abstract | Aerosolized contrast agents may improve the resolution of biomedical imaging modalities and enable more accurate diagnosis of lung diseases. Many iodinated compounds, such as diatrizoic acid, have been shown to be safe and useful for radiographic examination of the airways. Formulations of such compounds must be improved in order to allow imaging of the smallest airways. Here, diatrizoic acid nanoparticle agglomerates were created by assembling nanoparticles into inhalable microparticles that may augment deposition in the lung periphery. Nanoparticle agglomerates were fully characterized and safety was determined in vivo. After dry powder insufflation to rats, no acute alveolar tissue damage was observed 2 h post dose. Diatrizoic acid nanoparticle agglomerates possess the characteristics of an efficient and safe inhalable lung contrast agent. | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ | |
dc.subject | Diatrizoic acid | en_US |
dc.subject | Contrast medium | en_US |
dc.subject | Pulmonary delivery | en_US |
dc.subject | Dry powder | en_US |
dc.subject | Aerosols | en_US |
dc.subject | CT imaging | en_US |
dc.title | Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Berkland, Cory | |
kusw.kudepartment | Pharmaceutical Chemistry | en_US |
dc.identifier.doi | 10.1016/j.ijpharm.2010.03.009 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.